Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
| Website: | www.abbott.com |
| Main Phone: | +1 224 667-6100 |
| Address: | 100 Abbott Park Road |
| State: | IL |
| City / Town: | Abbott Park |
| Country: | US |
| Postal Code: | 60064-6400 |
| Exchange: | NYE |
| CEO: | Robert B. Ford |
| Employees: | 107000 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
This is the same test that is used in the White House.
Roche said its antibody test, Elecsys Anti-SARS-CoV-2, has a specificity rate of about 99.8% and sensitivity rate of 100%.
The new locations, with Abbott Laboratories’ faster diagnostic kit, will be able to handle 1,000 tests per day.
The test is expected to be the same quick-action test that Trump took on Thursday, which provides results in 15 minutes or less.
Equity markets moved from a raging bull to a bear market in just 23 days in February and March.
Bodysphere said it was working with the federal and state governments to deliver the test to the frontlines.
The S&P 500 rose 3.4% Monday for its fourth gain in the last five days.
Quarterly earnings season may be winding down, but the real earnings season – annual 10-K filing season – is ramping up.
Sales up 7% to $8.31 billion in Q4, beating estimates of $8.26 billion.
US healthcare spending will grow 5.5% annually through 2027, according to the Centers for Medicare and Medicaid Services.
Abbott manufactures and markets medical devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.
| Website: | www.abbott.com |
| Main Phone: | +1 224 667-6100 |
| Address: | 100 Abbott Park Road |
| State: | IL |
| City / Town: | Abbott Park |
| Country: | US |
| Postal Code: | 60064-6400 |
| Exchange: | NYE |
| CEO: | Robert B. Ford |
| Employees: | 107000 |
| NAICS: | Surgical and Medical Instrument Manufacturing(339112) |
This is the same test that is used in the White House.
Roche said its antibody test, Elecsys Anti-SARS-CoV-2, has a specificity rate of about 99.8% and sensitivity rate of 100%.
The new locations, with Abbott Laboratories’ faster diagnostic kit, will be able to handle 1,000 tests per day.
The test is expected to be the same quick-action test that Trump took on Thursday, which provides results in 15 minutes or less.
Equity markets moved from a raging bull to a bear market in just 23 days in February and March.
Bodysphere said it was working with the federal and state governments to deliver the test to the frontlines.
The S&P 500 rose 3.4% Monday for its fourth gain in the last five days.
Quarterly earnings season may be winding down, but the real earnings season – annual 10-K filing season – is ramping up.
Sales up 7% to $8.31 billion in Q4, beating estimates of $8.26 billion.
US healthcare spending will grow 5.5% annually through 2027, according to the Centers for Medicare and Medicaid Services.
| Last Price 108.69 | Change $ 0.90 | Change % 0.83 | Tick N/A |
| Bid 108.68 | Bid Size 100.00 | Ask 108.70 | Ask Size 200.00 |
| Open 107.57 | High 109.16 | Low 107.05 | Prev Close 107.79 |
| Last Trade | Volume 4.9 mi | 52 Wk Hi 114.20 | 52 Wk Low 61.62 |
| Market Cap 192.4 bi | Ex-Div Date | Div Rate 1.44 | Yield 1.3360 |
| Shares 1,770,529,999.00 | EPS (TTM) 1.89 | PE Ratio 57.00 | Exchange NYSE |
|
|
|
|
| Last 3 Mo | Last 12 Mo | |
|---|---|---|
| Number of Insider Trades | 32 | 614 |
| Number of Buys | 16 | 135 |
| Number of Sells | 16 | 479 |
| Net Activity | 9943 | 787821 |
| Last 10 Buys | Shares |
|---|---|
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Daniel J. Starks | 1,000 |
| Last 10 Sell | Shares |
|---|---|
| Daniel Gesua Sive Salvadori | 1,000 |
| Daniel Gesua Sive Salvadori | 1,000 |
| Sharon J. Bracken | 1,000 |
| Sharon J. Bracken | 1,000 |
| Sharon J. Bracken | 1,000 |
| Sharon J. Bracken | 1,000 |
| Jaime Contreras | 1,000 |
| Roger Bird | 1,000 |
| Roger Bird | 1,000 |
| Roger Bird | 1,000 |
| Current | 1 Week Ago | 2 Weeks Ago | 3 Weeks Ago | |
|---|---|---|---|---|
| High Target Price Estimate | 71 | 71 | 71 | 71 |
| Low Target Price Estimate | 56 | 56 | 56 | 56 |
| Mean Target Price Estimate | 67.12 | 67.12 | 67.12 | 67.12 |
| Standard Deviation | 4.66 | 4.66 | 4.66 | 4.66 |
| Date of Most Recent Estimate | 05/22/18 | 05/22/18 | 05/22/18 | 05/22/18 |
| Form Type | Form Description | Pages | Date |
|---|---|---|---|
| 3 | Initial statement of beneficial ownership of securities | 1 | 2018-06-15 |
| 8-K | Report of unscheduled material events or corporate changes. | 31 | 2018-06-08 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-07 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-06-05 |
| SD | Specialized Disclosure Report | 17 | 2018-05-31 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-21 |
| 4 | Statement of changes in beneficial ownership of securities | 1 | 2018-05-16 |
| Current | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 16 |
| Moderate Buy | 1 | 1 | 1 | 1 |
| Hold | 3 | 3 | 3 | 3 |
| Moderate Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Mean Rec. | 1.35 | 1.35 | 1.35 | 1.35 |
© 2020 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
Gathering Data... Please wait